Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats

BACKGROUND/AIM: Treatment with growth factors could be beneficial in both inflammatory bowel disease and experimental colitis. The aim of this study was to investigate the effect of Colony Stimulating Factor (CSF), and Recombinant Human (rHu) Granulocyte Stimulating Factor (GSF) in experimental coli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Res Int
Main Authors: Papalois, Apostolos E., Barbatis, Calypso, Chrysikos, Dimosthenis, Korontzi, Maria, Sideris, Michail, Pittaras, Theodoros, Triantafyllidi, Eleni, Nomikos, Alexandros, Triantafillidis, John K.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803744/
https://ncbi.nlm.nih.gov/pubmed/31687401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8298192
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados